Angiodynamics (ANGO) Accumulated Expenses (2011 - 2026)

Angiodynamics has reported Accumulated Expenses for 16 years, with the latest figure at $32.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 12.57% year-over-year to $32.3 million; the trailing twelve-month figure through Feb 2026 stood at $32.3 million (down 12.57% YoY), and the FY2025 full-year result was $35.5 million, down 13.58% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $32.3 million, up from $29.9 million in the prior quarter.
• The five-year high for Accumulated Expenses was $41.1 million in Q2 2024, with the low at $21.8 million in Q1 2023.
• Historically, Accumulated Expenses has averaged $30.8 million across 5 years, with a median of $29.9 million in 2025.
• Annual changes were most pronounced in 2024 — Accumulated Expenses soared 54.41% — and 2025, when it retreated 25.22%.
• Angiodynamics' Accumulated Expenses stood at $26.5 million in 2022, then advanced by 10.19% to $29.2 million in 2023, then soared by 36.54% to $39.9 million in 2024, then dropped by 25.22% to $29.9 million in 2025, then grew by 8.21% to $32.3 million in 2026.
• The last three Accumulated Expenses figures came in at $32.3 million (Q1 2026), $29.9 million (Q4 2025), and $27.7 million (Q3 2025), per Business Quant data.